Corvus Pharmaceuticals Ratios (2022-2025) | CRVS

Ratios Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Efficiency
Assets Average 96.92M86.44M74.29M63.22M58.12M54.99M48.75M42.82M52.32M61.69M63.86M64.17M74.45M84.97M
Equity Average 85.05M72.53M60.40M52.49M49.17M46.89M41.49M36.02M42.30M31.82M22.49M40.95M64.78M76.00M
Invested Capital 89.72M80.39M64.68M56.12M48.87M49.48M44.29M38.68M33.36M51.23M12.41M32.57M49.33M80.23M71.77M
Leverage & Solvency
Equity Ratio 0.890.870.810.820.840.850.850.850.830.790.210.470.830.900.89
Valuation
Enterprise Value -31.46M-28.48M-24.59M-13.16M-9.65M-7.66M-20.11M-12.62M-7.46M-14.84M-4.68M-8.74M-5.00M-14.69M-2.87M
Return Ratios
Return on Capital Employed -0.67%-0.60%-1.64%-0.53%-0.51%-0.49%
Return on Assets -0.10%-0.20%-0.30%-0.34%-0.38%-0.28%-0.80%-0.77%-0.43%-0.42%-0.02%
Return on Equity -0.12%-0.23%-0.35%-0.40%-0.45%-0.35%-1.54%-2.19%-0.67%-0.48%-0.02%